Patients with existing heart or kidney disease may benefit from starting SGLT-2 inhibitors therapy, while those with a higher risk of developing these conditions, such as obese patients and those with no cardiogenic stroke, may benefit more from GLP-1 RAs
All U Health does NOT take insurance or coupons but you may use your HSA or FSA cards
Ozempic (semaglutide) is a GLP-1 receptor agonist drug, and Zepbound is a dual receptor agonist that works on GIP and GLP-1 receptors in the body to reduce appetite and manage blood glucose levels
According to WHO, 400 million people are affected by G6PD deficiency in the world but in Colombia, the severe form prevalence is about 3% to 7%
Mechanistic reviews of ghrelin/GHSR-1a signaling frame Ipamorelin as a receptor agonist that harnesses the bodys own release machinery
Don't chase magic bullets